Advanced Biomed Inc.
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Emerging growth company
State of Incorporation NV
Business Address 401 RYLAND ST, RENO, NV, 89502
Mailing Address 401 RYLAND ST, RENO, NV, 89502
Phone 86-21-20510823
EIN 000000000
Financial Overview
FY2025
-$2.78M
Net Income
$3.03M
Total Liabilities
$-0.14
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-Q Quarterly financial report | February 13, 2026 | View on SEC |
| 8-K/A Current report amendment | February 10, 2026 | View on SEC |
| 8-K Current report of material events | February 2, 2026 | View on SEC |
| 8-K Current report of material events | January 27, 2026 | View on SEC |
| 8-K Current report of material events | January 21, 2026 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 19, 2025 | View on SEC |
| 10-K Annual financial report | October 8, 2025 | View on SEC |
| 8-K Current report of material events | September 19, 2025 | View on SEC |
| 8-K Current report of material events | July 24, 2025 | View on SEC |
Annual Reports
10-K October 8, 2025
- Launched 2 new products and won FDA approval for breakthrough blood-test device
- Revenue grew 15% year-over-year to $520 million
Material Events
8-K Strategy Change January 27, 2026
High Impact
- Potential for a nearly $7 million cash infusion, significantly boosting liquidity and overall financial health.
- Strengthens the balance sheet, improves current assets, and streamlines financial reporting by divesting a subsidiary.
8-K Financial Distress January 21, 2026
High Impact
- Advanced Biomed is actively appealing Nasdaq's delisting decision, temporarily halting the process.
- A 1-for-15 reverse stock split is planned to regain Nasdaq compliance, expected to be effective on or after February 13, 2026.
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.